Alkermes : ALKS

All Alkermes Articles

93 Articles

Jon C. Ogg | Apr 22, 2013 at 8:25 AM EDT

Top Analyst Downgrades and Cautious Views from Wall Street

Jon OggInvestors are used to seeing many Buy ratings from Wall St. analysts, but they often overlook or do not…

Jon C. Ogg | Apr 17, 2013 at 11:45 AM EDT

Merrill Lynch Offers Four Key Biotech Drug Updates

ThinkstockBiotech pipeline news and biotech drug news continues to hit. A report from Bank of America/Merrill Lynch is highlighting four small-cap…

Jon C. Ogg | Feb 6, 2013 at 10:05 AM EST

Years Later, MS Drug Ownership Consolidation — M&A Next?

ThinkstockBiogen Idec Inc. (NASDAQ: BIIB) may be a half decade or so late on this move, but as the saying goes “better…

Jon C. Ogg | Jan 17, 2013 at 8:42 AM EST

Top Analyst Upgrades and Downgrades (ADTN, ALKS, CBS, CSCO, GLW, DCI, ERJ, INCY, JNPR, MJN, MDT, REGN, SAP, LUV, VVUS, YUM, ZLTQ)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen so far from Wall St. research calls…

Jon C. Ogg | Oct 26, 2012 at 8:14 AM EDT

Top Analyst Upgrades and Downgrades (ALKS, AVT, KMX, CTCT, CME, DK, EXPD, HBAN, MPC, MYL, P, PSX, RCL, SPR, STJ, TRV)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Friday.…

Jon C. Ogg | Oct 18, 2012 at 8:37 AM EDT

Top Analyst Upgrades and Downgrades (ALKS, NLY, AAPL, APOL, CMA, COP, DB, DUK, HOG, INTC, LINE, POT, SDRL, STJ, VVUS, Z)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations we have seen from Wall St. research calls…

Jon C. Ogg | Aug 13, 2012 at 2:05 PM EDT

Elan’s Spin-Off Creates Buyout Hopes (ELN, BIIB, ALKS, PFE)

Elan Corporation, plc (NYSE: ELN) may be surging on news that it is going to spin off its drug research unit,…

Jon C. Ogg | Jul 11, 2012 at 8:24 AM EDT

Top Analyst Upgrades & Downgrades (AA, ALKS, AMZN, AAPL, BHP, CENX, CLF, CRK, DNDN, DUK, EMC, FST, HAL, IBM, MSFT, PAL, SAP, SPLS, WM)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Wednesday.…

Jon C. Ogg | Mar 28, 2012 at 9:52 AM EDT

The Inevitable Amylin Buyout (AMLN, BMY, LLY, ALKS)

If there was a merger candidate which ever made sense in biotech and pharma it is Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN). …

Jon C. Ogg | Feb 16, 2012 at 5:59 PM EST

Elan Shares of Alkermes Registered For Sale (ALKS, ELN)

Alkermes plc (NASDAQ: ALKS) has filed its paperwork with the Securities and Exchange Commission for the resale covering the potential…

Jon C. Ogg | Jan 30, 2012 at 2:27 PM EST

The Amylin Gains Could Have Even Been Larger (AMLN, ALKS, NVO)

Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is up 17.8% at $14.29 on word that the FDA finally gave its once-a-week diabetes…

Jon C. Ogg | Sep 26, 2011 at 8:25 AM EDT

Top Analyst Upgrades & Downgrades (AMD, ALKS, AMSG, ERTS, EXPE, FSLR, GXP, GMCR, GPRE, ITRI, NFLX, OXY, SLE, UTX)

Jon OggThese are some of this Monday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street…

Jon C. Ogg | Sep 14, 2011 at 8:12 AM EDT

Top Analyst Upgrades & Downgrades (ALKS, AMP, BWA, CSCO, CLB, DD, GTIV, HIG, JASO, JPM, JWN, NSC, ORCL, PFE, STP, TSL, UAL)

Jon OggThese are some of this Wednesday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street…

Jon C. Ogg | May 14, 2011 at 10:16 AM EDT

Top 6 Analyst Calls of the Week (ALKS, APO, DF, ETFC, PNSN, SPWRA)

Jon OggEach morning during the week we publish the top analyst upgrades and downgrades that we see in the market. …

Jon C. Ogg | May 13, 2011 at 2:01 PM EDT

Top Earnings Previews For The Week Ahead (JCP, LOW, URBN, DELL, HD, SKS, TJX, TSL, WMT, ALKS, BJ, DE, DDS, HPQ, PAAS, SPLS, TGT, ADSK, DLTR, GME, MPEL, CRM, SHLD, YGE)

It may seem like corporate earnings season is just about over, but next week we have a flurry of reports…

1 … 3 4 5 6 7

Alkermes : ALKS

All Alkermes Articles

Top Analyst Downgrades and Cautious Views from Wall Street

Merrill Lynch Offers Four Key Biotech Drug Updates

Years Later, MS Drug Ownership Consolidation — M&A Next?

Top Analyst Upgrades and Downgrades (ADTN, ALKS, CBS, CSCO, GLW, DCI, ERJ, INCY, JNPR, MJN, MDT, REGN, SAP, LUV, VVUS, YUM, ZLTQ)

Top Analyst Upgrades and Downgrades (ALKS, AVT, KMX, CTCT, CME, DK, EXPD, HBAN, MPC, MYL, P, PSX, RCL, SPR, STJ, TRV)

Top Analyst Upgrades and Downgrades (ALKS, NLY, AAPL, APOL, CMA, COP, DB, DUK, HOG, INTC, LINE, POT, SDRL, STJ, VVUS, Z)

Elan’s Spin-Off Creates Buyout Hopes (ELN, BIIB, ALKS, PFE)

Top Analyst Upgrades & Downgrades (AA, ALKS, AMZN, AAPL, BHP, CENX, CLF, CRK, DNDN, DUK, EMC, FST, HAL, IBM, MSFT, PAL, SAP, SPLS, WM)

The Inevitable Amylin Buyout (AMLN, BMY, LLY, ALKS)

Elan Shares of Alkermes Registered For Sale (ALKS, ELN)

The Amylin Gains Could Have Even Been Larger (AMLN, ALKS, NVO)

Top Analyst Upgrades & Downgrades (AMD, ALKS, AMSG, ERTS, EXPE, FSLR, GXP, GMCR, GPRE, ITRI, NFLX, OXY, SLE, UTX)

Top Analyst Upgrades & Downgrades (ALKS, AMP, BWA, CSCO, CLB, DD, GTIV, HIG, JASO, JPM, JWN, NSC, ORCL, PFE, STP, TSL, UAL)

Top 6 Analyst Calls of the Week (ALKS, APO, DF, ETFC, PNSN, SPWRA)

Top Earnings Previews For The Week Ahead (JCP, LOW, URBN, DELL, HD, SKS, TJX, TSL, WMT, ALKS, BJ, DE, DDS, HPQ, PAAS, SPLS, TGT, ADSK, DLTR, GME, MPEL, CRM, SHLD, YGE)

XRP Price Prediction: 3 AI Models Predict Where XRP Will Trade by December 2026

QDVO’s 32% Return Masks a Hidden Risk for Income Investors

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

Kevin Warsh Would Be a Hawk at the Fed, but Productivity Boom Could Prevail

Ray Dalio: ‘We’re On the Brink’ of Major Problems Within 2 Years

Alkermes : ALKS

All Alkermes Articles

Top Analyst Downgrades and Cautious Views from Wall Street

Merrill Lynch Offers Four Key Biotech Drug Updates

Years Later, MS Drug Ownership Consolidation — M&A Next?

Top Analyst Upgrades and Downgrades (ADTN, ALKS, CBS, CSCO, GLW, DCI, ERJ, INCY, JNPR, MJN, MDT, REGN, SAP, LUV, VVUS, YUM, ZLTQ)

Top Analyst Upgrades and Downgrades (ALKS, AVT, KMX, CTCT, CME, DK, EXPD, HBAN, MPC, MYL, P, PSX, RCL, SPR, STJ, TRV)

Top Analyst Upgrades and Downgrades (ALKS, NLY, AAPL, APOL, CMA, COP, DB, DUK, HOG, INTC, LINE, POT, SDRL, STJ, VVUS, Z)

Elan’s Spin-Off Creates Buyout Hopes (ELN, BIIB, ALKS, PFE)

Top Analyst Upgrades & Downgrades (AA, ALKS, AMZN, AAPL, BHP, CENX, CLF, CRK, DNDN, DUK, EMC, FST, HAL, IBM, MSFT, PAL, SAP, SPLS, WM)

The Inevitable Amylin Buyout (AMLN, BMY, LLY, ALKS)

Elan Shares of Alkermes Registered For Sale (ALKS, ELN)

The Amylin Gains Could Have Even Been Larger (AMLN, ALKS, NVO)

Top Analyst Upgrades & Downgrades (AMD, ALKS, AMSG, ERTS, EXPE, FSLR, GXP, GMCR, GPRE, ITRI, NFLX, OXY, SLE, UTX)

Top Analyst Upgrades & Downgrades (ALKS, AMP, BWA, CSCO, CLB, DD, GTIV, HIG, JASO, JPM, JWN, NSC, ORCL, PFE, STP, TSL, UAL)

Top 6 Analyst Calls of the Week (ALKS, APO, DF, ETFC, PNSN, SPWRA)

Top Earnings Previews For The Week Ahead (JCP, LOW, URBN, DELL, HD, SKS, TJX, TSL, WMT, ALKS, BJ, DE, DDS, HPQ, PAAS, SPLS, TGT, ADSK, DLTR, GME, MPEL, CRM, SHLD, YGE)

XRP Price Prediction: 3 AI Models Predict Where XRP Will Trade by December 2026

QDVO’s 32% Return Masks a Hidden Risk for Income Investors

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

Featured Reads

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk